Merck blood clot drug in limbo after mixed results

.

Merck blood clot drug in limbo after mixed results

On Saturday, drug-maker Merck & Co provided details about the last month-announced results of the tests of its experimental blood thinner `vorapaxar', revealing that despite the impressive effectiveness of the blood clot drug in bringing about a significant reduction in cardio vascular incidents in heart patients, worrisome bleeding was also witnessed in people who had suffered a stroke.

According to Merck, while the experimental drug, when combined with standard care, proved effective in bringing down the instances of cardio vascular events in heart patients, it also led to increased bleeding in some patients.

When Merck presented limited data from the study in February this year, the company had said that vorapaxar was proving to be an advantageous drug for heart patients. However, the drug-maker has now revealed that patients who had been administered vorapaxar were also experiencing excessive bleeding.

The Merck revelation, based on the results of the biggest heart-drug studies conducted thus far, implies that the vorapaxar blood clot preventer has shown mixed results; and has thus led to concerns whether the drug-maker will go ahead and seek regulatory approval for the drug.

Noting that the vorapaxar trial shows that there is "clearly a tradeoff here between the protective benefit and the risk of bleeding," Dr. David Morrow - who is a cardiologist from Brigham & Women's Hospital in Boston, and the leader of the trial - said: "Should the drug be approved, he said the challenge for doctors would be to withhold it from patients at likely higher bleeding risk."


Latest News

Groundbreaking operation experienced by Vicky the orangutan
Sleep positions say a lot about your relationship
Pet cat gives meningitis to kid
Bar set higher for foreign doctors to work in England
Nose can be a pathfinder
NPD: Xbox One and PS4 sales have surpassed 5 million and 7 million units respect
Nissan expands "No Charge to Charge" promotion, offers new EZ-Charge cards to Le
Dropbox acquires two startups --- Loom and Hackpad
Alex Springer CEO Mathias Dopfner strongly criticizes Google in open letter
NWS issues flood warnings around Maine rivers
Microsoft launches All-in-One Media Keyboard
Bigwig tech companies and wireless carriers back anti-theft tools agreement